With leverage and multiple expansion no longer carrying the return, value has to be created inside the business — operational alpha.
AuDX is a governed commercial diagnostic, using data science, decision science, and AI. It finds where value is trapped and quantifies what is realistically recoverable on an evidence-graded P10/P50/P90 basis — every figure reliability-scored, overlap-tested, and traceable to source — then sequences the interventions a board can stand behind.
Portfolio value creation · pre-deal value reads · 100-day plans · pre-exit EBITDA improvement.
Data and Decision Science as a Service (D²SaaS): a governed diagnostic in which a deterministic engine owns the arithmetic, AI accelerates extraction, classification, and QA, and a human operator governs every release. Designed for board, CFO, and lender scrutiny — transparent assumptions, evidence grades, a calculation audit trail, and explicit limits.
AuDX is built for the moments when someone accountable for value has a question their reporting can't answer.
Boards, CFOs, and investors increasingly know unrealised value sits inside the business. The hard part is proving where it is trapped, what is realistically recoverable, and which interventions are worth acting on first.
The incumbent answer — the strategy houses and Big 4 — typically runs three to six weeks and often longer at full scope, and is built for transaction defensibility rather than value recovery.
Built from eighteen years of board-level commercial leadership across FTSE 100 retail, global B2B events and information services, enterprise technology across 30 European markets, UK hospitality and resorts, and capital-markets fintech. AuDX codifies that judgement — the patterns, benchmarks, and intervention hierarchies — into a deterministic diagnostic architecture: the engine owns the arithmetic, AI accelerates extraction, classification, and QA, and a human operator governs every release. You are buying an institutional asset, not renting an individual's time.
Every diagnostic produces finding cards — board-ready artefacts that isolate one commercial signal and translate it into a quantified, governed, actionable intervention. Note how the headline number is never the reported number: every figure is confidence-adjusted and implementation-adjusted before it reaches the board.
Illustrative finding — synthetic subscription-data business. Not a client result.
Most commercial reviews run intake → analyse → report, and stop. AuDX starts before the data arrives and doesn't finish until value recovery is evidenced. Seven stages, each governed, each gated.
Two numbers, never conflated: the size of the opportunity, and what a board can stand behind. Weak evidence is discounted, nothing is double-counted, and theoretical value never reaches the board — so no one chases ghost revenue. CVR is value creation measured at the point of decision, not in hindsight — risk-adjusted, so a board can commit to it.
Every engagement delivers a complete, board-ready value case: the CVR report, the underlying calculation model and audit trail, a governed card for every material finding, and the realisation plan — evidence-graded end to end, and defensible in front of a CFO, an investment committee, or a lender. Four artefacts:
Full-scope commercial due diligence is essential when an investment committee needs the complete market, customer, and competitor view. The sharper distinction is what you hold at the end:
| SITUATION | FULL-SCOPE CDD | AuDX |
|---|---|---|
| Investment committee needs full external market & customer diligence | Best fit | Supporting value input |
| Deal is smaller, faster, or sector-familiar | Often disproportionate | Strong fit — 5–15 working days |
| Portfolio company needs a 100-day commercial value plan | Not designed for this | Strong fit |
| Pre-exit EBITDA improvement sequencing | Partial fit | Strong fit |
| Advisory firm needs a quantified value case inside its own deliverable | Manual, bespoke | Built for it — licensed via AuDX Partner |
Built to survive a CFO, a board, and a lender: ranges, not single numbers — P10/P50/P90 on driver-level inputs, with Monte Carlo simulation and Beta-PERT sampling across value ranges; every finding scored — calibrated reliability scoring, with Empirical Bayes shrinkage where evidence is thin, so no finding is reported at full value unless the evidence supports it; no double-counting, no overclaim — overlap control, implementation adjustment, dual reporting, an explicit assumption and limitation log, and quarterly backtesting against realised EBITDA. Theoretical value is never reported as recoverable. Client data is processed only inside the agreed engagement environment, and purged at the end of it.
Each line carries its own diagnostic logic and calibration — what they share is the engine, the evidence discipline, and the governed release.
The same evidence standard that makes a finding defensible also defines where the method shouldn't run. AuDX declines engagements it cannot govern to standard:
AuDX runs only where it can produce defensible value recovery.
AuDX applies sector-specific diagnostic logic — the right signals, benchmarks, and intervention hierarchies for each business model.
Built for PE-backed and mid-market businesses. Applied to any complex commercial model.
Thirty minutes, in confidence: your situation, the data available, and whether AuDX can produce a defensible result. No fee, no commitment — if there is a fit, the diagnostic begins on a defined, time-bound schedule.